Scam Watch: Klotho Neurosciences / Greenland Mines (GRML)

This one popped up on a CNBC commercial today. Let's break down what you're actually looking at.

The ticker is GRML. The company name on file is Greenland Mines Ltd. The display name says Klotho Neurosciences. The "about" section says they do cell and gene therapy for neurodegenerative diseases. The news feed is about securing an icebreaker for a mining field program in Greenland and launching an environmental baseline study at the Skaergaard mining site.

This is a bio turned shell. Started as something, pivoted into something else, kept the old ticker, and now it's neither. We've seen this pattern before. A company with no product, no revenue, and no clear identity that reinvents itself every few quarters hoping one story sticks long enough to raise capital.

The numbers tell you everything. $20 million market cap. Zero revenue. Zero analyst coverage. Zero earnings estimates. Trading at $0.32, down from $3.91. Just got a 180-day extension from Nasdaq to stay above $1 or get delisted. Beta of 1.94 because the price action is pure noise.

And they're buying CNBC commercials. A $20 million company with no revenue paying for television airtime is not a company trying to build a product. It's a ticker trying to find retail buyers.

When the marketing budget is bigger than the R&D budget, you're not looking at a biotech. You're looking at a promotion.

Don't touch it.